Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Tianmi Yang, Yi Xiao, Yangfan Cheng, Jingxuan Huang, Qianqian Wei, Chunyu Li, Huifang Shang
BACKGROUND: Biological ageing is one of the principal risk factors for neurodegenerative diseases. It is becoming increasingly clear that acceleration of DNA methylation age, as measured by the epigenetic clock, is closely associated with many age-related diseases. METHODS: We searched the PubMed and Web of Science databases to identify eligible studies reporting epigenetic clocks in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD)...
March 24, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#2
JOURNAL ARTICLE
Alexander Gordon, Thomas Roe, María Dolores Villar-Martínez, David Moreno-Ajona, Peter J Goadsby, Jan Hoffmann
BACKGROUND: Greater occipital nerve (GON) blockade is a short-term preventive therapy for cluster headache (CH). We conducted a systematic review to evaluate the effectiveness and safety of GON blockade in patients with CH. METHODS: On 23 October 2020, we searched MEDLINE, Embase, Embase Classic, PsycINFO, CINAHL, CENTRAL and Web of Science databases from their inception date. Studies included participants with a CH diagnosis who received corticosteroid and local anaesthetic suboccipital region injections...
March 22, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#3
LETTER
Ester di Giacomo, Biagio Eugenio Leone, Massimo Clerici, Fabio Grassia
No abstract text is available yet for this article.
March 22, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#4
JOURNAL ARTICLE
Masahiro Ando, Yujiro Higuchi, Jun-Hui Yuan, Akiko Yoshimura, Mika Dozono, Takahiro Hobara, Fumikazu Kojima, Yutaka Noguchi, Mika Takeuchi, Jun Takei, Yu Hiramatsu, Satoshi Nozuma, Tomonori Nakamura, Yusuke Sakiyama, Akihiro Hashiguchi, Eiji Matsuura, Yuji Okamoto, Jun Sone, Hiroshi Takashima
BACKGROUND: NOTCH2NLC GGC repeat expansions have been associated with various neurogenerative disorders, including neuronal intranuclear inclusion disease and inherited peripheral neuropathies (IPNs). However, only a few NOTCH2NLC -related disease studies in IPN have been reported, and the clinical and genetic spectra remain unclear. Thus, this study aimed to describe the clinical and genetic manifestations of NOTCH2NLC -related IPNs. METHOD: Among 2692 Japanese patients clinically diagnosed with IPN/Charcot-Marie-Tooth disease (CMT), we analysed NOTCH2NLC repeat expansion in 1783 unrelated patients without a genetic diagnosis...
March 22, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#5
JOURNAL ARTICLE
Aaron Trinidade, Verónica Cabreira, Joel A Goebel, Jeffrey P Staab, Diego Kaski, Jon Stone
BACKGROUND: The literature on predictors of persistent postural-perceptual dizziness (PPPD) following peripheral vestibular insults has not been systematically reviewed. METHODS: We systematically reviewed studies on predictors of PPPD and its four predecessors (phobic postural vertigo, space-motion discomfort, chronic subjective dizziness and visual vertigo). Investigations focused on new onset chronic dizziness following peripheral vestibular insults, with a minimum follow-up of 3 months...
March 20, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#6
JOURNAL ARTICLE
Bryndís Baldvinsdóttir, Erik Kronvall, Elisabeth Ronne-Engström, Per Enblad, Peter Lindvall, Helena Aineskog, Steen Friðriksson, Paula Klurfan, Mikael Svensson, Peter Alpkvist, Jan Hillman, Johanna Eneling, Ola G Nilsson
BACKGROUND: Adverse events (AEs) or complications may arise secondary to the treatment of aneurysmal subarachnoid haemorrhage (SAH). The aim of this study was to identify AEs associated with microsurgical occlusion of ruptured aneurysms, as well as to analyse their risk factors and impact on functional outcome. METHODS: Patients with aneurysmal SAH admitted to the neurosurgical centres in Sweden were prospectively registered during a 3.5-year period (2014-2018)...
March 17, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#7
LETTER
Araceli Alonso-Canovas, Monica M Kurtis, Victor Gomez-Mayordomo, Daniel Macías-García, Álvaro Gutiérrez Viedma, Elisabet Mondragón Rezola, Javier Pagonabarraga, Lidia Aranzabal Orgaz, Jaime Masjuan, Juan Carlos Martinez-Castrillo, Isabel Pareés
No abstract text is available yet for this article.
March 8, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#8
JOURNAL ARTICLE
Ruth Leadbetter, Michael MacAskill, Daniell J Myall, Bruce V Taylor, Purwa Joshi, Deborah F Mason
BACKGROUND: Mortality data from Europe and North America show a shorter life expectancy for people with multiple sclerosis (MS). It is not known if a similar mortality risk exists in the southern hemisphere. We analysed the mortality outcomes of a comprehensive New Zealand (NZ) MS cohort, 15 years postrecruitment. METHODS: All participants of the nationwide 2006 NZ MS prevalence study were included and mortality outcomes were compared with life table data from the NZ population using classic survival analyses, standardised mortality ratios (SMRs) and excess death rates (EDRs)...
March 7, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#9
JOURNAL ARTICLE
Mingming Lu, Hongtao Zhang, Shitong Liu, Dongqing Liu, Peng Peng, Fangbin Hao, Fei Yuan, Yuan Liu, Fugeng Sheng, Lichen Zhang, Xihai Zhao, Yao He, Cong Han, Jianming Cai
OBJECTIVES: We aimed to compare the long-term outcomes and surgical benefits between moyamoya disease (MMD) and atherosclerosis-associated moyamoya vasculopathy (AS-MMV) using high-resolution MRI (HRMRI). METHODS: MMV patients were retrospectively included and divided into the MMD and AS-MMV groups according to vessel wall features on HRMRI. Kaplan-Meier survival and Cox regression were performed to compare the incidence of cerebrovascular events and prognosis of encephaloduroarteriosynangiosis (EDAS) treatment between MMD and AS-MMV...
March 3, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#10
JOURNAL ARTICLE
Han Li, Chen-Chen Tan, Lan Tan, Wei Xu
BACKGROUND: Subjective cognitive decline (SCD) is an early manifestation of cognitive deterioration (CD) in some individuals. Therefore, it is worthwhile to conduct a systematic review and meta-analysis to summarise predictors of CD among individuals with SCD. METHOD: PubMed, Embase, and Cochrane Library were searched until May 2022. Longitudinal studies that assessed factors associated with CD in SCD population were included. Multivariable-adjusted effect estimates were pooled using random-effects models...
March 3, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#11
JOURNAL ARTICLE
Radek Kaiser, Lucia Kantorová, Alena Langaufová, Simona Slezáková, Dagmar Tučková, Miloslav Klugar, Zdeněk Klézl, Pavel Barsa, Jan Cienciala, Richard Hajdúk, Lumír Hrabálek, Roman Kučera, David Netuka, Martin Prýmek, Martin Repko, Martin Smrčka, Jan Štulík
OBJECTIVE: To determine the efficacy of adding instrumented spinal fusion to decompression to treat degenerative spondylolisthesis (DS). DESIGN: Systematic review with meta-analysis. DATA SOURCES: MEDLINE, Embase, Emcare, Cochrane Library, CINAHL, Scopus, ProQuest Dissertations & Theses Global, ClinicalTrials.gov and WHO International Clinical Trials Registry Platform from inception to May 2022. ELIGIBILITY CRITERIA FOR STUDY SELECTION: Randomised controlled trials (RCTs) comparing decompression with instrumented fusion to decompression alone in patients with DS...
February 27, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#12
JOURNAL ARTICLE
Frederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, Claudia Chien, Orhan Aktas, Philipp Albrecht, Marius Ringelstein, Anitha Dcunha, Lekha Pandit, Elena H Martinez-Lapiscina, Bernardo Sanchez-Dalmau, Pablo Villoslada, Jacqueline Palace, Adriana Roca-Fernández, Maria Isabel Leite, Srilakshmi M Sharma, Letizia Leocani, Marco Pisa, Marta Radaelli, Marco Aurélio Lana-Peixoto, Mariana Andrade Fontenelle, Joachim Havla, Fereshteh Ashtari, Rahele Kafieh, Alireza Dehghani, Mohsen Pourazizi, Romain Marignier, Alvaro Cobo-Calvo, Nasrin Asgari, Anu Jacob, Saif Huda, Yang Mao-Draayer, Ari J Green, Rachel Kenney, Michael R Yeaman, Terry J Smith, Lawrence Cook, Alexander U Brandt, Friedemann Paul, Axel Petzold
BACKGROUND: The novel optic neuritis (ON) diagnostic criteria include intereye differences (IED) of optical coherence tomography (OCT) parameters. IED has proven valuable for ON diagnosis in multiple sclerosis but has not been evaluated in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders (AQP4+NMOSD). We evaluated the diagnostic accuracy of intereye absolute (IEAD) and percentage difference (IEPD) in AQP4+NMOSD after unilateral ON >6 months before OCT as compared with healthy controls (HC)...
February 21, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#13
JOURNAL ARTICLE
Sara Carta, Do Le Duy, Veronique Rogemond, Nathalie Derache, Hugo Chaumont, Agnès Fromont, Sebastien Cabasson, Marine Boudot de la Motte, Jerome Honnorat, Romain Marignier
BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSDs) are a group of diseases mainly characterised by recurrent optic neuritis and/or myelitis. Most cases are associated with a pathogenic antibody against aquaporin-4 (AQP4-Ab), while some patients display autoantibodies targeting the myelin oligodendrocyte glycoprotein (myelin oligodendrocyte glycoprotein antibodies (MOG-Abs)). Anti-Argonaute antibodies (Ago-Abs) were first described in patients with rheumatological conditions and were recently reported as a potential biomarker in patients with neurological disorders...
February 21, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#14
JOURNAL ARTICLE
Sarah-Naomi James, Yu-Jie Chiou, Nasri Fatih, Louisa P Needham, Jonathan M Schott, Marcus Richards
BACKGROUND: To assess how timing, frequency and maintenance of being physically active, spanning over 30 years in adulthood, is associated with later-life cognitive function. METHODS: Participants (n=1417, 53% female) were from the prospective longitudinal cohort study, 1946 British birth cohort. Participation in leisure time physical activity was reported five times between ages 36 and 69, categorised into: not active (no participation in physical activity/month); moderately active (participated 1-4 times/month); most active (participated 5 or more times/month)...
February 21, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#15
REVIEW
Charlotte Schubert, Lea Steinberg, Julia Peper, Caren Ramien, Kerstin Hellwig, Sascha Köpke, Alessandra Solari, Andrea Giordano, Stefan M Gold, Tim Friede, Christoph Heesen, Anne Christin Rahn
The influence of pregnancy on the course of multiple sclerosis (MS) has long been controversial. While historical evidence suggests a substantial decline in relapse rates during pregnancy followed by a rebound in the postpartum period, more recent work yielded equivocal results. We performed a systematic review and meta-analysis on data from cohort studies to determine whether women with MS experience increased relapse rates after delivery. A systematic literature search was conducted in the databases MEDLINE and Epistemonikos on the topic 'motherhood choice in MS' in March 2022...
February 20, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#16
REVIEW
Jordan N Alves, Britta U Westner, Andreas Højlund, Rimona Sharon Weil, Sarang S Dalal
Parkinson's disease is caused by degeneration of dopaminergic neurons, originating in the substantia nigra pars compacta and characterised by bradykinesia, rest tremor and rigidity. In addition, visual disorders and retinal abnormalities are often present and can be identified by decreased visual acuity, abnormal spatial contrast sensitivity or even difficulty in complex visual task completion. Because of their early onset in patients with de novo Parkinson's disease, the anatomical retinal changes and electrophysiological modification could be valuable markers even at early stages of the disease...
February 17, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#17
LETTER
Anderson Rodrigues Brandão de Paiva, André Luiz Santos Pessoa, Paulo Ribeiro Nóbrega, Cristiane Araujo Martins Moreno, David S Lynch, Lucas Mitsuo Taniguti, João Paulo Kitajima, Fernando Freua, Bruno Della-Ripa, Paulina Cunha, Isabella Peixoto de Barcelos, Lúcia Inês Macedo-Souza, Carlos Augusto Takeuchi, Antônio Milton Silva Garcia, Flávia Nardes, Ramiro Fontão, Sérgio Antônio Antoniuk, Monica Troncoso, Norma Spécola, Consuelo Durand, Bianca de Aguiar Coelho Silva Madeiro, Maria Juliana Rodovalho Doriqui, Diane Vergara, Henry Houlden, Fernando Kok
No abstract text is available yet for this article.
February 3, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#18
REVIEW
Sean W Willemse, Peter Harley, Ruben P A van Eijk, Koen C Demaegd, Pavol Zelina, R Jeroen Pasterkamp, Philip van Damme, Caroline Ingre, Wouter van Rheenen, Jan H Veldink, Matthew C Kiernan, Ammar Al-Chalabi, Leonard H van den Berg, Pietro Fratta, Michael A van Es
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options and an incompletely understood pathophysiology. Although genomewide association studies (GWAS) have advanced our understanding of the disease, the precise manner in which risk polymorphisms contribute to disease pathogenesis remains unclear. Of relevance, GWAS have shown that a polymorphism (rs12608932) in the UNC13A gene is associated with risk for both ALS and frontotemporal dementia (FTD). Homozygosity for the C-allele at rs12608932 modifies the ALS phenotype, as these patients are more likely to have bulbar-onset disease, cognitive impairment and FTD at baseline as well as shorter survival...
February 3, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#19
JOURNAL ARTICLE
Xin Lin, Yuanhao Yang, Valery Fuh-Ngwa, Xianyong Yin, Steve Simpson-Yap, Ingrid van der Mei, Simon A Broadley, Anne-Louise Ponsonby, Kathryn P Burdon, Bruce V Taylor, Yuan Zhou
BACKGROUND: There are currently no specific biomarkers for multiple sclerosis (MS). Identifying robust biomarkers for MS is crucial to improve disease diagnosis and management. METHODS: This study first used six Mendelian randomisation methods to assess causal relationship of 174 metabolites with MS, incorporating data from European-ancestry metabolomics (n=8569-86 507) and MS (n=14 802 MS cases, 26 703 controls) genomewide association studies...
February 2, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
#20
JOURNAL ARTICLE
Zahra Nasr, Vinicius Andreoli Schoeps, Amin Ziaei, Akash Virupakshaiah, Cameron Adams, T Charles Casper, Michael Waltz, John Rose, Moses Rodriguez, Jan-Mendelt Tillema, Tanuja Chitnis, Jennifer S Graves, Leslie Benson, Mary Rensel, Lauren Krupp, Amy T Waldman, Bianca Weinstock-Guttman, Tim Lotze, Benjamin Greenberg, Gregory Aaen, Soe Mar, Teri Schreiner, Janace Hart, Steve Simpson-Yap, Clementina Mesaros, Lisa F Barcellos, Emmanuelle Waubant
BACKGROUND: We previously reported an association between household chemical exposures and an increased risk of paediatric-onset multiple sclerosis. METHODS: Using a case-control paediatric multiple sclerosis study, gene-environment interaction between exposure to household chemicals and genotypes for risk of paediatric-onset multiple sclerosis was estimated.Genetic risk factors of interest included the two major HLA multiple sclerosis risk factors, the presence of DRB1*15 and the absence of A*02, and multiple sclerosis risk variants within the metabolic pathways of common household toxic chemicals, including IL-6 (rs2069852), BCL-2 (rs2187163) and NFKB1 (rs7665090)...
February 1, 2023: Journal of Neurology, Neurosurgery, and Psychiatry
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
